Bepiastine

Abstract

The invention discloses bepiastine. A formula consists of the following components by weight: 666g of bear gall powder and 3,200g of mile swertia, wherein a mile swertia raw material is required to be taken from a nationally-specified place, i.e., Mile in Yunnan Province; and the content of bear gall powder is required to reach a national medicament standard. A preparation method comprises the following steps of: extracting mile swertia twice by taking water as a solvent at the temperature of 80-90 DEG C, every time for 4 hours; combining extracting solutions; filtering with a micro water filter membrane; concentrating a filtrate in vacuum at a low temperature into thick paste of 1.30-1.35 (50 DEG C); drying into dry extract under reduced pressure; smashing the bear gall powder, mile swertia and dry extract respectively; sieving with a 120-mesh sieve, mixing uniformly and sterilizing; pilling with diluted ethanol, drying and preparing to 1,000g; and inspecting, performing split charging and warehousing. The formula of the bepiastine is scientific and reasonable, the requirements of mile swertia and bear gall powder raw materials are strict, a bepiastine product has stable quality and a perfect production process, and production conditions are consistent with Good Manufacturing Practice (GMP), i.e., a medicament production GMP standard. The bepiastine product has remarkable curative effects on the treatment of acute and chronic hepatitis, cholecystitis and gall-stone, resisting of arrhythmia, reduction in cholesterol in blood and triglyceride and prevention of hyperlipoidemia and renal hypertension. After long-term use, the bepiastine is free from untoward effects, and is safe and reliable.

Description

1. Technical field: [0001] The present invention is an organic combination of herbal medicine and animal medicine developed by applying medicinal chemistry extraction, separation, refining and traditional Chinese medicine preparation technology to treat acute and chronic hepatitis, cholecystitis, gallstones, antiarrhythmia, lower blood cholesterol and triglyceride , Therapeutic drug for preventing hyperlipidemia and renal hypertension. 2. Background technology: [0002] Before this application was filed, others had filed a similar patent application to the State Intellectual Property Office, but due to various reasons such as: incomplete data, immature production process, and incomplete clinical test data of formula composition, the patent was not obtained. [0003] On the basis of the previous patent application, the present invention introduces the latest technology of extracting, separating and refining the active ingredients of medicines and traditional Chinese medicine ...

AI Technical Summary

Problems solved by technology

[0002] Before this application was filed, others had filed a similar patent application to the State Intellectual Property Office, but due to various reasons such as: incomplete data, immature production process, incomplete clinical test data of formula composition, and no patent